me cfs and glutathione Chain reaction in cells may be driving low energy in ME/CFS patients Chronic fatigue syndrome linked to
Description
K., & Morozov, V
Phenotypes caused by pathogenic mtDNA mutations We next considered mtDNA sequence variation in UKB (Methods), with an initial focus on well-established, disease-associated mtDNA variants
It is worth noting that Amylyx Pharmaceuticals announced the results of the phase 3 PHOENIX trial of AMX0035 for the treatment of ALS in 2024
Over time, it's likely that chelation will continue to be studied as a treatment for certain conditions
